Puerarin improves Dioscorea bulbifera L.-induced liver injury by regulating drug transporters and the Nrf2/NF-κB/Bcl-2 signaling pathway
Journal of Pharmacy and Pharmacology · 02.12.2024 · 76 (12) · 1620-1633
DOI: 10.1093/jpp/rgae123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 07.10.2024. Verfasst von Xin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Shaanxi University of Chinese Medicine, No. 1 Middle Section of Century Avenue, Xianyang, 712046, People's Republic of Ch…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, NF-kappa B, Isoflavones, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Innovative Talent Program of Shaanxi University of Chinese Medicine.
Abstract (Originalsprache)
Purpose
Investigate the protective effect and mechanism of Puerarin (PU) against Dioscorea bulbifera L. (DB)-induced liver injury. Materials and methods The protective effect of PU against DB-induced liver injury was evaluated by the present animal experiment, which assessed the pathological changes in the liver of mice and detected Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Alkaline phosphatase (AKP), as well as inflammation and oxidative stress-related indexes. Finally, the transcription and expression of related proteins were detected using western blot and quantitative reverse transcription (PCR) techniques.
Results
PU significantly increased body weight, reduced liver index, and attenuated pathological changes in the liver compared to the DB group. It also decreased levels of AST, ALT, AKP, tumor necrosis factor-α, interleukin-1β, and malondialdehyde while increasing interleukin-10 levels and superoxide dismutase activity. Additionally, it upregulated inhibitor of NF-κB (IκB-α), B-cell lymphoma-2 (Bcl-2), Nuclear respiratory factor 2 (Nrf2), and Heme oxygenase 1 (HO-1) expression while down-regulating p-NF-κB p65 and bcl2-associated x (Bax) expression in the liver. Furthermore, PU upregulated protein and gene expression levels of Multidrug resistance-associated protein2, bile salt export pump, p-glycoprotein, and UDP-glucuronyltransferase 1A1 (UGT1A1) as well.
Conclusion
PU mitigates DB-induced liver injury by regulating the expression of drug transporters and modulating the Nrf2/NF-κB/Bcl-2 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Shaanxi University of Chinese Medicine, No. 1 Middle Section of Century Avenue, Xianyang, 712046, People's Republic of China.
- Key Laboratory of Pharmacodynamic Mechanism and Material Basis of Traditional Chinese Medicine, Shaanxi Administration of Traditional Chinese Medicine, Xianyang, 712046, People's Republic of China.
ORCID-Profile: Xin Wang
Förderung
- National Natural Science Foundation of China
- Science and Technology Innovative Talent Program of Shaanxi University of Chinese Medicine
Zitieren
APA
Wang, X., Zhang, Y., Zhu, H., Shi, L., Shi, Y., Cao, S., Liu, J., & Xie, Y. (2024). Puerarin improves Dioscorea bulbifera L.-induced liver injury by regulating drug transporters and the Nrf2/NF-κB/Bcl-2 signaling pathway. Journal of Pharmacy and Pharmacology, 76(12), 1620-1633. https://doi.org/10.1093/jpp/rgae123
Vancouver
Wang X, Zhang Y, Zhu H, Shi L, Shi Y, Cao S, et al. Puerarin improves Dioscorea bulbifera L.-induced liver injury by regulating drug transporters and the Nrf2/NF-κB/Bcl-2 signaling pathway. Journal of Pharmacy and Pharmacology. 2024;76(12):1620-1633. doi:10.1093/jpp/rgae123
BibTeX
@article{Wang2024,
author = {Wang, Xin and Zhang, Yuhan and Zhu, Hongzhe and Shi, Leilei and Shi, Yong and Cao, Shanshan and Liu, Jiping and Xie, Yundong},
title = {Puerarin improves Dioscorea bulbifera L.-induced liver injury by regulating drug transporters and the Nrf2/NF-κB/Bcl-2 signaling pathway},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
volume = {76},
number = {12},
pages = {1620--1633},
doi = {10.1093/jpp/rgae123}
}
EUVIMED